ADRB2 rs1042718: What Your Genotype Means for Fitness and Metabolism
The ADRB2 rs1042718 variant is a common genetic change located in the beta-2 adrenergic receptor gene. It has been studied for its potential roles in metabolic regulation, exercise-induced fat breakdown, and physical endurance performance.
What each genotype means
Typical ADRB2 expression profile
This genotype represents the common form of the rs1042718 variant in the ADRB2 gene. Research indicates this variant acts as a quantitative expression trait locus (eQTL), and this specific genotype is associated with baseline levels of beta-2 adrenergic receptor activity in relevant tissues. As evidence regarding its direct impact on fitness or metabolic outcomes remains limited, this profile should be viewed as a standard genetic baseline.
This is a common genotype found globally, consistent with the high frequency of the C allele.
Varied ADRB2 expression profile
Carrying one copy of the G allele at this position may influence the expression levels of the beta-2 adrenergic receptor. Recent studies have linked this variant to differences in brown adipose tissue activity and cold-induced thermogenesis, though the clinical significance of these findings is still being explored. Because the evidence is limited, this genotype does not provide a definitive prediction of metabolic or exercise-related traits.
This heterozygous genotype is frequently observed in diverse populations, reflecting the common nature of the G allele.
Alternative ADRB2 expression profile
This genotype involves two copies of the G allele, which has been identified as a quantitative expression trait locus (eQTL) for the ADRB2 gene. While some research suggests an association with brown adipose tissue function and thermogenesis, the overall evidence linking this specific genotype to athletic performance or metabolic health remains limited and mixed. It is not a diagnostic marker, and any concerns regarding metabolic health or exercise physiology should be discussed with a qualified healthcare professional.
This genotype is present in a significant portion of the global population, consistent with the reported minor allele frequency of approximately 0.40.
Understanding the ADRB2 Gene and rs1042718
The ADRB2 gene provides instructions for making the beta-2 adrenergic receptor. This protein is found on the surface of many cell types, including those in the heart, lungs, and adipose tissue. It belongs to a class of receptors that respond to catecholamines, such as epinephrine and norepinephrine. When these signaling molecules bind to the receptor, it triggers a cascade of cellular responses, such as increasing heart rate, relaxing smooth muscles in the airways, and stimulating the breakdown of stored fats into energy. The variant rs1042718 is a single nucleotide polymorphism where a cytosine is substituted for a guanine. This specific change results in an amino acid substitution, often referred to as Gly16Arg, within the protein structure. Because this change occurs in a region of the receptor involved in signaling and receptor downregulation, researchers have long hypothesized that this variant might alter how cells respond to exercise or stress. By studying this SNP, scientists aim to understand the subtle variations in human physiology that might influence how different individuals respond to physical activity and metabolic demands.
Research Associations and Evidence Strength
The relationship between ADRB2 rs1042718 and fitness-related traits remains a subject of ongoing scientific inquiry. In the context of exercise, some studies have explored whether this variant influences lipolysis, the process by which the body breaks down fat to provide fuel during prolonged exertion. While some small-scale studies have suggested that specific genotypes might be associated with variations in endurance performance or the metabolic response to exercise, the evidence is considered limited and often inconsistent across different cohorts. Large-scale meta-analyses and data from the GWAS Catalog indicate that while ADRB2 variants are critical in clinical contexts, such as asthma management, their impact on athletic performance and complex metabolic traits in the general population is likely modest and influenced by many other genetic and environmental factors. Many associations initially reported in smaller studies have failed to replicate in larger, more diverse populations. Consequently, it is important to view these associations as statistical tendencies observed in research settings rather than as deterministic factors that define an individual's physical potential or metabolic health.
Interpreting Your Genetic Information
Genetic variants like rs1042718 provide a fascinating glimpse into the diversity of human biology, but they are not blueprints for your health or abilities. When considering information about fitness variants, it is essential to remember that physical performance, metabolism, and body composition are polygenic traits, meaning they are influenced by thousands of genetic markers, and are heavily shaped by diet, training, sleep, and lifestyle. No single SNP can accurately predict whether you will be a successful endurance athlete or how your body will respond to a specific exercise program. Furthermore, because the evidence linking this variant to fitness is limited and mixed, it cannot be used to create personalized training or nutritional plans. If you are interested in optimizing your health or athletic performance, focus on evidence-based lifestyle practices. If you have questions about specific medications that interact with the ADRB2 receptor, such as those used for respiratory conditions, you must discuss dosing and treatment plans with your clinician or pharmacist, as they can provide advice tailored to your personal medical history.
How common is this variant?
The rs1042718 variant is widely distributed across global populations, with a minor allele frequency of approximately 0.40. This high frequency confirms that rs1042718 is a common variation rather than a rare mutation.
Frequently asked questions
Is rs1042718 a reliable test for athletic potential?
No. Current scientific evidence is too limited to suggest that this variant can predict athletic performance, and fitness is far too complex to be determined by a single genetic marker.
Does this variant affect asthma medication?
ADRB2 variants are known to be involved in the response to certain asthma medications, such as beta-agonists. If you take medication for asthma or other respiratory issues, consult your doctor or pharmacist about how your genetic profile might influence your treatment.
Why do different studies show different results for this SNP?
Discrepancies often arise due to differences in study size, the ethnic background of participants, and the specific exercise protocols used. Statistical associations found in small groups often disappear when tested in larger, more diverse populations.
Can I use this information to change my diet?
No. While the variant is linked to metabolic regulation, it is not a validated tool for dietary guidance. Always consult with a registered dietitian or physician for personalized nutritional advice.
Sources & further reading
Educational information only, last refreshed 9/29/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1042718?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ADRB2
Synonymous polymorphism in the beta-2 adrenergic receptor (Gln27Glu) modulating receptor down-regulation.
The Gln27Glu variant in the beta-2 adrenergic receptor is associated with metabolic and vascular responses to exercise.
Modulates beta-2 adrenergic receptor expression and cardiovascular reactivity.
This variant in the beta-2 adrenergic receptor gene is associated with differential responses to beta-agonist therapy in asthma patients.
Functional variant in the beta-2 adrenergic receptor linked to metabolic rate and cardiovascular reactivity.
This variant in the beta-2 adrenergic receptor gene is associated with altered responses to asthma medications and bronchodilators.